| 2015 | 2016 | 2017 | 2018 | 2019 | 2020 | 2021 | 2022 | 2023 | 2024 | |
|---|---|---|---|---|---|---|---|---|---|---|
| Sales - EUR | - | 0 | 3.753 | 15.112 | - | 11.220 | 15.228 | 7.967 | 0 | 0 |
| Total Income - EUR | - | 0 | 3.753 | 15.112 | - | 11.220 | 15.228 | 7.972 | 0 | 0 |
| Total Expenses - EUR | - | 89 | 3.504 | 14.007 | - | 20.474 | 25.027 | 25.937 | 0 | 17.773 |
| Gross Profit/Loss - EUR | - | -89 | 249 | 1.105 | - | -9.254 | -9.799 | -17.965 | 0 | -17.773 |
| Net Profit/Loss - EUR | - | -89 | 211 | 656 | - | -9.568 | -10.165 | -18.156 | 0 | -17.773 |
| Employees | - | 0 | 0 | 0 | - | 2 | 1 | 0 | 1 | 1 |
Check the financial reports for the company - Diavet Doc Pets Srl
| 2015 | 2016 | 2017 | 2018 | 2019 | 2020 | 2021 | 2022 | 2023 | 2024 | |
|---|---|---|---|---|---|---|---|---|---|---|
| Fixed Assets | - | 112 | 0 | 3.388 | - | 2.427 | 1.966 | 1.564 | 0 | 742 |
| Current Assets | - | 66 | 1.164 | 5.788 | - | 11.020 | 13.512 | 2.544 | 0 | 4.321 |
| Inventories | - | 0 | 1.031 | 5.725 | - | 10.185 | 13.074 | 2.407 | 0 | 4.056 |
| Receivables | - | 0 | 0 | 145 | - | 45 | 44 | 45 | 0 | 44 |
| Cash | - | 66 | 133 | -82 | - | 789 | 394 | 92 | 0 | 222 |
| Shareholders Funds | - | -45 | 167 | 820 | - | -20.213 | -29.930 | -48.179 | 0 | -65.537 |
| Social Capital | - | 45 | 44 | 43 | - | 41 | 40 | 41 | 0 | 40 |
| Debts | - | 223 | 998 | 8.356 | - | 33.660 | 45.409 | 52.287 | 0 | 70.601 |
| Income in Advance | - | 0 | 0 | 0 | - | 0 | 0 | 0 | 0 | 0 |
| Exchange rate - RON | 4.9743 | 4.9465 | 4.9315 | 4.9468 | 4.8371 | 4.7454 | 4.6535 | 4.5681 | 4.4908 | 4.445 |
| Main CAEN | "7500 - 7500" | |||||||||
| CAEN Financial Year |
7500
|
|||||||||
Comments - Diavet Doc Pets Srl